An anti-CD3/anti–CLL-1 bispecific antibody for the treatment of acute myeloid leukemia von Leong, Steven R., Sukumaran, Siddharth, Hristopoulos, Maria, Totpal, Klara, Stainton, Shannon, Lu, Elizabeth, Wong, Alfred, Tam, Lucinda, Newman, Robert, Vuillemenot, Brian R., Ellerman, Diego, Gu, Chen, Mathieu, Mary, Dennis, Mark S., Nguyen, Allen, Zheng, Bing, Zhang, Crystal, Lee, Genee, Chu, Yu-Waye, Prell, Rodney A., Lin, Kedan, Laing, Steven T., Polson, Andrew G.

Volltext

Cathepsin B Is Dispensable for Cellular Processing of Cathepsin B-Cleavable Antibody-Drug Conjugates von Caculitan, Niña G, Dela Cruz Chuh, Josefa, Ma, Yong, Zhang, Donglu, Kozak, Katherine R, Liu, Yichin, Pillow, Thomas H, Sadowsky, Jack, Cheung, Tommy K, Phung, Qui, Haley, Benjamin, Lee, Byoung-Chul, Akita, Robert W, Sliwkowski, Mark X, Polson, Andrew G

Volltext

An Anti-CLL-1 Antibody-Drug Conjugate for the Treatment of Acute Myeloid Leukemia von Zheng, Bing, Yu, Shang-Fan, Del Rosario, Geoffrey, Leong, Steven R, Lee, Genee Y, Vij, Rajesh, Chiu, Cecilia, Liang, Wei-Ching, Wu, Yan, Chalouni, Cecile, Sadowsky, Jack, Clark, Vanessa, Hendricks, Angela, Poon, Kirsten Achilles, Chu, Wayne, Pillow, Thomas, Schutten, Melissa M, Flygare, John, Polson, Andrew G

Volltext

Therapeutic potential of an anti-CD79b antibody–drug conjugate, anti–CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma von Dornan, David, Bennett, Fiona, Chen, Yvonne, Dennis, Mark, Eaton, Dan, Elkins, Kristi, French, Dorothy, Go, Mary Ann T., Jack, Andrew, Junutula, Jagath R., Koeppen, Hartmut, Lau, Jeffrey, McBride, Jacqueline, Rawstron, Andy, Shi, Xiaoyan, Yu, Nancy, Yu, Shang-Fan, Yue, Peng, Zheng, Bing, Ebens, Allen, Polson, Andrew G.

Volltext

Development of T-cell engagers selective for cells co-expressing two antigens von Dicara, Danielle M, Bhakta, Sunil, Go, Mary Ann, Ziai, James, Firestein, Ron, Forrest, Bill, Gu, Chen, Leong, Steven R, Lee, Genee, Yu, Shang-Fan, Polson, Andrew G, Agard, Nicholas J

Volltext

Antibody-Drug Conjugates for the Treatment of Non-Hodgkin's Lymphoma: Target and Linker-Drug Selection von POLSON, Andrew G, CALEMINE-FENAUX, Jill, FRANTZ, Gretchen, FUJI, Reina N, GRAY, Alane, HARDEN, Kristin, INGLE, Gladys S, KLJAVIN, Noelyn M, KOEPPEN, Hartmut, NELSON, Christopher, PRABHU, Saileta, RAAB, Helga, CHAN, Pamela, ROSS, Sarajane, STEPHAN, Jean-Philippe, SCALES, Suzie J, SPENCER, Susan D, VANDLEN, Richard, WRANIK, Bernd, YU, Shang-Fan, BING ZHENG, EBENS, Allen, CHANG, Wesley, CHRISTENSEN, Erin, CLARK, Suzanna, DE SAUVAGE, Frederic J, EATON, Dan, ELKINS, Kristi, ELLIOTT, J. Michael

Volltext

Preclinical optimization of Ly6E-targeted ADCs for increased durability and efficacy of anti-tumor response von Dela Cruz Chuh, Josefa, Go, MaryAnn, Chen, Yvonne, Guo, Jun, Rafidi, Hanine, Mandikian, Danielle, Sun, Yonglian, Lin, Zhonghua, Schneider, Kellen, Zhang, Pamela, Vij, Rajesh, Sharpnack, Danielle, Chan, Pamela, de la Cruz, Cecile, Sadowsky, Jack, Seshasayee, Dhaya, Koerber, James T, Pillow, Thomas H, Phillips, Gail D, Rowntree, Rebecca K, Boswell, C Andrew, Kozak, Katherine R, Polson, Andrew G, Polakis, Paul, Yu, Shang-Fan, Dragovich, Peter S, Agard, Nicholas J

Volltext

Expression pattern of the human FcRH/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia von Polson, Andrew G., Zheng, Bing, Elkins, Kristi, Chang, Wesley, Du, Changchun, Dowd, Patrick, Yen, Lulu, Tan, Christine, Hongo, Jo-Anne, Koeppen, Hartmut, Ebens, Allen

Volltext

Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma von Polson, Andrew G., Yu, Shang-Fan, Elkins, Kristi, Zheng, Bing, Clark, Suzanna, Ingle, Gladys S., Slaga, Dionysos S., Giere, Lynne, Du, Changchun, Tan, Christine, Hongo, Jo-Anne, Gogineni, Alvin, Cole, Mary J., Vandlen, Richard, Stephan, Jean-Philippe, Young, Judy, Chang, Wesley, Scales, Suzie J., Ross, Sarajane, Eaton, Dan, Ebens, Allen

Volltext

A Novel Anti-CD22 Anthracycline-Based Antibody-Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs von Yu, Shang-Fan, Zheng, Bing, Go, MaryAnn, Lau, Jeff, Spencer, Susan, Raab, Helga, Soriano, Robert, Jhunjhunwala, Suchit, Cohen, Robert, Caruso, Michele, Polakis, Paul, Flygare, John, Polson, Andrew G

Volltext

Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B‐cell Precursor Acute Lymphoblastic Leukemia von Lenk, Lennart, Winterberg, Dorothee, Vogiatzi, Fotini, Laqua, Anna, Spory, Lea, Mayar, Ahmad, Dietterle, Anna, Münch, Gina, Vokuhl, Christian, Richter, Julia, Polson, Andrew G., Schüler, Thomas, Kahlert, Ulf D., Peipp, Matthias, Valerius, Thomas, Schrappe, Martin, Cario, Gunnar, Jumaa, Hassan, Hobeika, Elias, Brüggemann, Monika, Alsadeq, Ameera, Schewe, Denis M.

Volltext

Anti-CD79B Antibody-Drug Conjugate DCDS0780A in Patients with B-Cell Non-Hodgkin Lymphoma: Phase 1 Dose-Escalation Study von Herrera, Alex F, Patel, Manish R, Burke, John M, Advani, Ranjana, Cheson, Bruce D, Sharman, Jeff P, Penuel, Elicia, Polson, Andrew G, Liao, Chen Di, Li, Chunze, Schuth, Eva, Vaze, Anjali, Samineni, Divya, Elstrom, Rebecca, Cooper, James, Diefenbach, Catherine

Volltext

Toward an Effective Targeted Chemotherapy for Multiple Myeloma von Polson, Andrew G, Sliwkowski, Mark X

Volltext

In vivo effects of targeting CD79b with antibodies and antibody-drug conjugates von Zheng, Bing, Fuji, Reina N, Elkins, Kristi, Yu, Shang-Fan, Fuh, Franklin K, Chuh, Josefa, Tan, Christine, Hongo, Jo-Anne, Raab, Helga, Kozak, Katherine R, Williams, Marna, McDorman, Elena, Eaton, Dan, Ebens, Allen, Polson, Andrew G

Volltext

A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myeloma von Kakiuchi-Kiyota, Satoko, Ross, Thorsten, Wallweber, Heidi Ackerly, Kiefer, James R., Schutten, Melissa M., Adedeji, Adeyemi O., Cai, Hao, Hendricks, Robert, Cohen, Sivan, Myneni, Srividya, Liu, Luna, Fullerton, Aaron, Corr, Nicholas, Yu, Lanlan, de Almeida Nagata, Denise, Zhong, Shelly, Leong, Steven R., Li, Ji, Nakamura, Rin, Sumiyoshi, Teiko, Li, Jinze, Ovacik, Ayse Meric, Zheng, Bing, Dillon, Mike, Spiess, Christoph, Wingert, Susanne, Rajkovic, Erich, Ellwanger, Kristina, Reusch, Uwe, Polson, Andrew G.

Volltext

The cryptophycins as potent payloads for antibody drug conjugates von Verma, Vishal A., Pillow, Thomas H., DePalatis, Laura, Li, Guangmin, Phillips, Gail Lewis, Polson, Andrew G., Raab, Helga E., Spencer, Susan, Zheng, Bing

Volltext

Calicheamicin Antibody-Drug Conjugates with Improved Properties von Vollmar, Breanna S, Frantz, Chris, Schutten, Melissa M, Zhong, Fiona, Del Rosario, Geoffrey, Go, Mary Ann T, Yu, Shang-Fan, Leipold, Douglas D, Kamath, Amrita V, Ng, Carl, Xu, Keyang, Dela Cruz-Chuh, Josefa, Kozak, Katherine R, Chen, Jinhua, Xu, Zijin, Wai, John, Adhikari, Pragya, Erickson, Hans K, Dragovich, Peter S, Polson, Andrew G, Pillow, Thomas H

Volltext

The successes and limitations of preclinical studies in predicting the pharmacodynamics and safety of cell‐surface‐targeted biological agents in patients von Polson, Andrew G, Fuji, Reina N

Volltext

Evaluation and use of an anti‐cynomolgus monkey CD79b surrogate antibody–drug conjugate to enable clinical development of polatuzumab vedotin von Li, Dongwei, Lee, Donna, Dere, Randall C., Zheng, Bing, Yu, Shang‐Fan, Fuh, Franklin K., Kozak, Katherine R., Chung, Shan, Bumbaca Yadav, Daniela, Nazzal, Denise, Danilenko, Dimitry, Go, Mary Ann T., Williams, Marna, Polson, Andrew G., Poon, Kirsten Achilles, Prabhu, Saileta

Volltext

Novel Anti-LY6G6D/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Colorectal Cancer von Wang, Peiyin, Sun, Liping L, Clark, Robyn, Hristopoulos, Maria, Chiu, Cecilia P C, Dillon, Michael, Lin, WeiYu, Lo, Amy A, Chalsani, Sreedevi, Das Thakur, Meghna, Zimmerman Savill, Kristin M, Rougé, Lionel, Lupardus, Patrick, Piskol, Robert, Husain, Bushra, Ellerman, Diego, Shivva, Vittal, Leong, Steven R, Ovacik, Meric, Totpal, Klara, Wu, Yan, Spiess, Christoph, Lee, Genee, Leipold, Douglas D, Polson, Andrew G

Volltext